chitosan has been researched along with ro13-9904 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hafez, MM; Zaki, NM | 1 |
| Chen, X; Dong, X; He, C; Li, Z; Yuan, B | 1 |
| Arfan, M; Khan, JA; Latif, U; Mushtaq, S; Rabbani, F; Yameen, MA | 1 |
| Al-Zahrani, MH; Alshubaily, FA | 1 |
| El-Ghanam, AM; Mahmoud, ME; Mohamed, RHA; Saad, SR | 1 |
| Boughdady, M; Maghrabia, A; Meshali, M | 1 |
| Abramchuk, SS; Bartoshevich, AA; Beklemishev, MK; Doroshenko, IA; Ezhov, AA; Klyachko, NL; Krivtsov, GG; Lebedeva, AN; Lebedeva, MI; Podrugina, TA; Senyavin, VM; Vlasova, KY; Zakharenkova, SA | 1 |
| Abbasi, SA; Ali, S; Andleeb, S; Awan, UA; Imdad, K; Mughal, TA; Nasreen, S; Raja, SA | 1 |
8 other study(ies) available for chitosan and ro13-9904
| Article | Year |
|---|---|
Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Caco-2 Cells; Ceftriaxone; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Cytophotometry; Dose-Response Relationship, Drug; Drug Carriers; Hemolysis; Humans; Inhibitory Concentration 50; Intestinal Mucosa; Macrophages; Mice; Microscopy, Confocal; Nanoparticles; Nanotechnology; Particle Size; Permeability; Salmonella typhimurium; Solubility; Technology, Pharmaceutical | 2012 |
Injectable Polysaccharide Hydrogels as Biocompatible Platforms for Localized and Sustained Delivery of Antibiotics for Preventing Local Infections.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Ceftriaxone; Cell Line; Cell Survival; Chitosan; Delayed-Action Preparations; Dextrans; Escherichia coli; Freeze Drying; Hydrogels; Injections; Male; Materials Testing; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Polysaccharides; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Biocompatible biodegradable polymeric antibacterial nanoparticles for enhancing the effects of a third-generation cephalosporin against resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Ceftriaxone; Chitosan; Disease Models, Animal; Drug Synergism; Escherichia coli; Escherichia coli Infections; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Microbial Viability; Nanoparticles; Neutropenia; Staphylococcal Infections | 2017 |
Appliance of fungal chitosan/ceftriaxone nano-composite to strengthen and sustain their antimicrobial potentiality against drug resistant bacteria.
Topics: Anti-Infective Agents; Bacteria; Ceftriaxone; Chitosan; Drug Resistance, Neoplasm; Microbial Sensitivity Tests; Nanocomposites; Particle Size; Spectrum Analysis | 2019 |
Enhanced adsorption of Levofloxacin and Ceftriaxone antibiotics from water by assembled composite of nanotitanium oxide/chitosan/nano-bentonite.
Topics: Adsorption; Bentonite; Ceftriaxone; Chitosan; Kinetics; Levofloxacin; Nanocomposites; Titanium; Water | 2020 |
Design and Optimization of New Enteric Nanoparticles of Ceftriaxone for Oral Delivery: In vitro and in vivo Assessments.
Topics: Administration, Oral; Animals; Biological Availability; Ceftriaxone; Chitosan; Drug Carriers; Nanoparticles; Particle Size; Rabbits; Spectroscopy, Fourier Transform Infrared | 2021 |
Imaging-Guided Delivery of a Hydrophilic Drug to Eukaryotic Cells Based on Its Hydrophobic Ion Pairing with Poly(hexamethylene guanidine) in a Maleated Chitosan Carrier.
Topics: Carbocyanines; Ceftriaxone; Chitosan; Drug Carriers; Drug Delivery Systems; Eukaryotic Cells; Guanidines; Humans; Hydrophobic and Hydrophilic Interactions; Ions; Molecular Structure | 2021 |
Screening of Antibacterial Efficacy of Chitosan Encapsulated Probiotics (Lactococcus lactis and Lactobacillus curvattus) against Clinical Bacterial Pathogens.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Buffaloes; Ceftriaxone; Cephalothin; Cephradine; Chitosan; Chloramphenicol; Ciprofloxacin; Erythromycin; Lactobacillus; Lactococcus lactis; Probiotics; Tetracyclines; Tobramycin | 2022 |